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Twelve patients developed herpes simplex (HSV) hepatitis a median of 18 days after solid or-
gan transplantation. This is earlier than cytomegalovirus hepatitis, which usually occurs 30-40 
days after transplantation. Eight recipients (67%) died, and in seven, the diagnosis was made 
at autopsy or <48 h before death. Clinical manifestations associated with mortality were hypoten-
sion, disseminated intravascular coagulation (DIC), metabolic acidosis, gastrointestinal bleed-
ing, and bacteremia. Laboratory abnormalities at diagnosis associated with mortality were high 
creatinine, low platelet counts, prolonged partial thromboplastin time, and a high percentage 
of band forms on the blood smear. Disseminated HSV disease was noted in four of six patients 
who had an autopsy and included involvement of lungs in three and the gastrointestinal tract 
in three. Five recipients developed DIC and all died. Pathologically, HSV hepatitis has two forms, 
focal and diffuse. All three patients with diffuse liver pathology died. However, three of seven 
with focal liver pathology survived with antiviral therapy, which suggests that early diagnosis 
and treatment may be lifesaving. None of these patients had received prophylactic acyclovir. It 
is possible that acyclovir prophylaxis may be able to prevent this disease. 
Herpes simplex virus (HSV) hepatitis is considered rare 
[1]. It has been observed most frequently as part of dissemi-
nated HSV in immunologically compromised patients or dur-
ing pregnancy. Sporadic cases have been reported from this 
institution in renal transplant recipients and have ended fa-
tally [2, 3], as have most cases reported in the literature. Here 
we report 12 cases that occurred after solid organ transplan-
tation over a 9-year period (1980-1988). This series is large 
enough to allow us to determine the approximate frequency 
of HSV hepatitis in our transplantation popUlation; to pre-
sent the effect of viral dissemination, the nature of the liver 
pathology, and the range of clinical and laboratory charac-
teristics of the disease; and to investigate prognostic factors. 
Materials and Methods 
Definitions. Cases of HSV hepatitis were diagnosed by labora-
tory, histologic, and clinical findings of one or more of the follow-
ing in liver tissue from a biopsy or autopsy: isolation of HSV, positive 
immunoperoxidase staining for HSV antigen, or histology showing 
intranuclear inclusion bodies and pathology consistent with HSV 
lesions. In one case there was no liver tissue to examine, and the 
diagnosis was made by isolation of HSV from multiple sites outside 
the liver, including buffy coat, and clinical evidence of fulminant 
hepatitis. The histologic pattern of liver involvement with HSV was 
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used to classify hepatitis as focal or diffuse. Disseminated HSV dis-
ease was defined as involvement of two or more organs discovered 
at autopsy. Involvement of skin confined to the oral or genital areas 
alone was not considered to represent dissemination. Disseminated 
intravascular coagulation (DIC) was defined by clinical evidence of 
bleeding from multiple sites, thrombocytopenia, and prolongation 
of prothrombin time (PT) and partial thromboplastin time (PTT). 
Laboratory methods. Tissue specimens obtained by biopsy or 
at autopsy were examined after routine staining and processing for 
detection of HSV antigen by immunoperoxidase staining and, on 
occasion, processed for isolation of HSV. Other specimens obtained 
from transplant recipients for viral isolation included throat wash, 
urine, buffy coat, bronchial secretions, and tissue. Specimens were 
inoculated onto tube monolayers of human embryonic kidney cells 
and observed for cytopathic effect typical of HSV. In some cases, 
the viral isolates were typed by direct immunofluorescence with 
monoclonal antibodies specific for HSV-I and HSV-2 (Syva; Genetic 
Systems, Seattle). 
When available, sera from recipients and donors were assayed for 
neutralizing antibody against HSV or for specific antibody against 
HSV-l or HSV-2 using the type-specific glycoproteins gGl and gG2 
in an immunodot test adapted from methods described elsewhere 
[4, 5]. 
Statistical analysis. The x2 test was used for analysis of propor-
tional differences between dichotomous variables. 
Results 
Case identification. Cases were identified by computer 
search for HSV isolates in liver tissue from either biopsies 
or autopsies from the virology laboratory and by search of 
pathology records for HSV hepatitis. As shown in table 1, 
the liver biopsy or autopsy specimens in 10 of 11 cases stained 
positive for HSV by immunoperoxidase; intranuclear inclu-
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Table 1. Selected demographic, pathologic, and other characteristics of patients with herpes simplex virus hepatitis. 
---
~ 
Days 
diagnosed 
after Method 
Out- transplant of diagnosis Dis- Start of 
come, Type of Sexl (retrans- in liver Other sites of Liver semi- acyclovir Type of 
patient transplant age plant) (type of specimen) involvement DIe pathology nation treatment infection 
------- ----._-
Death 
1 Heart M/45 2 years Immunoperoxidase Lung, pancreas, Yes Focal Yes None Reactivation 
(autopsy) adrenals, esophagus, 
stomach, throat 
2 Liver F/26 18 Immunoperoxidase Lung, larynx, trachea, Yes Diffuse Yes None Reactivation 
(autopsy) bladder 
3 Kidney M/47 15 Isolation, Spleen, esophagus Yes Diffuse Yes None Primary 
immunoperoxidase 
(autopsy) 
4 Kidney M/38 20 Isolation, Buffy coat, throat Yes Diffuse No 48 h before Primary 
immunoperoxidase death 
(autopsy) 
5 Kidney MI21 16 NO Buffy coat, throat, urine Yes NO NA Day of death Primary 
6 Liver M/36 21 (4) Immunoperoxidase Thigh No Focal NA 4 weeks Reactivation 
(biopsy) before 
death (for 
2 weeks) 
7 Liver F/42 46 (16) Immunoperoxidase Throat, urine No Focal No None Reactivation 
(autopsy) 
8 Liver F/51 25 Immunoperoxidase Lung, larynx, trachea, No Focal Yes None Reactivation 
(autopsy) esophagus, stomach, 
adrenals 
Survival 
9 Liver F/24 30 Immunoperoxidase NO No Focal NA At diagnosis Reactivation 
(biopsy) 
10 Liver F/26 5 Isolation, NO No Focal NA At diagnosis Reactivation 
immunoperoxidase 
(biopsy) 
II Liver F/54 14 Immunoperoxidase Throat, thigh No Focal NA At diagnosis Primary 
(biopsy) 
12 Liver F129 6 Isolation (biopsy) NO No Negative NA At diagnosis Reactivation 
-- --~ -----~ 
NOTE. DIe = disseminated intravascular coagulation; ND = not done; NA = not ascertainable. 
sion bodies were seen in 7 of the 10 specimens. One case was 
diagnosed by isolation of HSV from the liver biopsy speci-
men. The one case without a liver biopsy was diagnosed by 
liver function test abnormalities showing fulminant hepati-
tis, DIe, and isolation of HSV from the buffy coat, urine, 
and throat. 
Patient demographics and frequency of HSV hepatitis. 
Twelve cases of HSV hepatitis occurred in solid organ trans-
plant recipients: eight were liver recipients, three were kid-
ney recipients, and one was a heart recipient (table 1). These 
cases were diagnosed between 1980 and September 1988, dur-
ing which period 3536 liver, kidney, and heart transplant oper-
ations were done. The overall frequency of HSV hepatitis was 
0.3% (table 2) and did not differ among kidney, heart, and 
liver recipients. The male-to-female ratio was 5 :7, and the 
mean age was 37 years (range, 21-54). 
Viral isolation. Of 12 cases, 8 had HSV isolated antemor-
tem or at autopsy. Of six liver specimens sent for viral isola-
Table 2. Incidence of herpes simplex virus (HSV) hepatitis after 
organ transplantation in Pittsburgh, 1980-1988. 
- ------~--------
No. of Frequency 
Type of Total no. patients with (cases per 
transplant of patients HSV hepatitis thousand) 
Kidney 1423 3 2.11 
Heart 449 I 2.23 
Liver 1664 8 4.81 
Total 3536 12 3.39 
tion, four (67 %) yielded HSV. Between 1 and 13 specimens 
obtained from these cases were submitted for viral isolation. 
Seventy-nine specimens (liver biopsy culture, throat culture, 
urine culture, and others) were taken within 60 days of trans-
plantation, and 17 (22 %) of these were positive for HSV. The 
time of onset of HSV infection after transplantation could be 
assessed for eight recipients, and six had positive viral cul-
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tures within 20 days of transplantation. This is consistent with 
our previous experience that HSV shedding, HSV mucocu-
taneous lesions, and dissemination usually occur early after 
transplantation [2, 3, 6). 
HSV hepatitis occurred as early as 5 days after transplan-
tation (median, 18; range, 5-46). In one patient, however, 
HSV hepatitis occurred >2 years after transplantation. The 
infection appeared to have spread from an occult focus ofHSV 
esophagitis while the patient was intubated in the intensive 
care unit. Thus, some small risk of HSV hepatitis persists 
long after transplantation. The usual timing ofHSV hepatitis 
is earlier than cytomegalovirus (CMV) hepatitis, which peaks 
30-40 days after transplantation (figure 1). The 35 cases of 
CMV hepatitis shown occurred at our institution between July 
1987 and September 1988 (unpublished data). The cases were 
diagnosed by histology of liver biopsies showing inclusion 
bodies suggestive of CMV and isolation of CMV from at least 
one site. The liver biopsies were usually done to investigate 
elevation of liver enzymes. 
Dissemination of HSV and extent of liver lesions. Visceral 
dissemination of HSV could be ascertained only at autopsy. 
Four (67%) of the six patients with autopsies had visceral 
disseminated HSV disease of two or more organs. Evidence 
ofHSV was found in the lungs of three patients; two had con-
comitant involvement of the larynx and trachea, and two had 
esophageal involvement. These cases may represent contigu-
ous spread of HSV to the lung [7]. Other organs involved in-
cluded stomach, pancreas, adrenals, spleen, and bladder. Of 
note, three of four patients with disseminated HSV infection 
had overwhelming disease accompanied by DIC; only two 
of these had diffuse HSV hepatitis. Conversely, one patient 
with diffuse hepatitis had DIC but di.d not have dissemination 
at autopsy. 
Of ten cases with histologic evidence of HSV hepatitis, three 
had diffuse involvement of the liver and seven had only focal 
involvement. All patients with diffuse hepatitis died, whereas 
three of seven with focal hepatitis survived. The pathology 
of focal and diffuse HSV hepatitis is illustrated in figure 2. 
Type of HSV infection. Of the 12 recipients, 8 (67 %) were 
seropositive for HSV before transplantation and thus either 
developed reactivation of HSV infection or were reinfected 
(table 1). The other 4 (33 %) were seronegative for HSV be-
fore transplantation and seemed to have primary infection. 
We were able to type the viral isolates from five patients; 
HSV-l was recovered from patient 3 and HSV-2 was recov-
ered from patients 4,5, 10, and 12. However, patient 11, who 
was seronegative for both HSV-l and HSV-2 before transplan-
tation, acquired antibody to HSV-2 after transplantation. Since 
the donor was seropositive only for HSV-2, it is possible the 
infection was acquired from the donor organ, as has been pre-
viously reported [3]. Patient 2, who was seronegative fur HSV-l 
but seropositive for HSV-2 before transplantation, acquired 
antibody to HSV-l after transplantation. It is possible that this 
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Figure 1. Diagnosis of herpes simplex virus (HSV) hepatitis (12 
patients) and cytomegalovirus (CMV) hepatitis (35 patients) by days 
after transplantation. 
infection was also acquired from the donor organ, since the 
donor was seropositive for both HSV-l and HSV-2. 
Clinical manifestations. The most common laboratory and 
clinical findings on the day of diagnosis were fever (tempera-
ture >38.5°C on one or more occasions before or on the day 
of diagnosis) in 10, abnormal chest radiograph in 11, increased 
percentage of band forms (>5 % of total white count) in 11, 
elevated liver enzymes (serum aspartate aminotransferase 
[SGOT) and serum alanine aminotransferase [SGPT] >40 
lUll) in 10, elevated bilirubin (>1.5 mgldl) in 11, throm-
bocytopenia « 100,000 platelets/ml) in 9, and abdominal pain 
and tenderness in 10. Patients were febrile 1-19 days (mean, 
6) before the diagnosis was established. The chest radiologic 
changes (pleural effusion, atelectasis, consolidation) were not 
necessarily related to HSV pneumonia. Of three patients with 
histologic evidence of HSV in the lung, chest radiographs 
showed patchy bilateral infiltrates in one, left lower lobe den-
sity in one, and bilateral pleural effusions in one. 
Three patients had skin lesions caused by HSV, one of whom 
died. Patient 1 had multiple ulcerated skin lesions distributed 
on the chest and extremities, as well as disseminated HSV 
at autopsy. The other three patients with evidence of dissemi-
nated HSV at autopsy did not have herpetic skin lesions. Pa-
tients 6 and 11 had vesicular lesions on their thighs from which 
HSV was isolated. 
Eight patients (67%) died, and in seven the diagnosis was 
made either at autopsy or within 24-48 h of death when the 
patient was moribund. Table 3 shows the clinical and labora-
tory findings associated with death. The laboratory abnor-
malities that were more common in patients who died were 
a low platelet count, a high percentage of band forms on the 
blood smear, prolonged PTT (but not prolonged PT), and a 
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high creatinine level at diagnosis. Granulocytosis (>85 % neu-
trophils) was prominent in all patients, and the mean number 
of neutrophils at time of diagnosis was 7655 ceIJs/mm3. Nine 
patients had platelet counts <lOO,OOO/mm3 at diagnosis 
(mean, 70,lOO/mm3). Increased levels of SGOT and SGPT 
were not associated with increased mortality but were 
markedly elevated in most patients. The median level for 
SGOT was 366 lUll (range, 37-6343) and for SGPT was 175 
IUIl (range 33-3865). Only two patients had normal liver en-
zymes (table 1, patients 7 and 12). HSV was isolated from 
Figure 2. Liver specimens showing diffuse and focal hepatitis. 
Left, macroscopic specimen (2900 g) with diffuse necrosis due to 
herpes simplex virus (HSY) hepatitis (patient 4, table I). Middle 
and bottom: micrographs of hematoxylin- and eosin-stained sections. 
Middle left and right: section of above specimen showing diffuse 
HSY hepatitis of the portal zone (original magnification, x42) and 
typical intranuclear herpetic inclusions (XI70) , respectively. Bot-
tom left and right: liver biopsy (patient 8, table I) showing focal 
HSY hepatitis (x42) and typical intranuclear herpetic inclusions 
( XllO), respectively. 
a liver biopsy in patient 12 but there was no pathology of the 
liver, and patient 7 had focal hepatitis diagnosed at autopsy. 
It is notable that all patients who had hypotension, meta-
bolic acidosis, gastrointestinal bleeding, OIC, and bacteremia 
died (table 3). Seven of eight patients with renal failure (cre-
atinine >1.5 mgldl) died. The degree of renal failure at diag-
nosis was correlated with mortality and was multifactorial. 
The main contributory causes were hypotension, renal toxic-
ity due to cyclosporine, and hepatorenal syndrome. 
Immunosuppression . All patients were maintained on cy-
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Table 3. Laboratory and clinical data associated with mortality in 12 cases of herpes simplex virus 
hepatitis. 
------
No. of patients who 
died/no. with 
laboratory value 
Median (range) 
Normal value for patients .. median > median 
----- ------------~---------------Data 
p 
Laboratory 
No. platelets 
% band forms 
Partial thromboplastin 
time 
Creatinine 
Clinical 
150,000-450.000 
<5% 
18-32 s 
0.5-1.4 mg/dl 
45.000 
(14,000-210,000) 
25% 
(4%-45%) 
38 
(20.1-120) 
3.5 
(0.7-6.4) 
6/6 2/6 <.01 
2/6 6/6 <.02 
317 5/5 <.05 
2/6 6/6 <.02 
----
No. of patients 
who died/no. 
of patients 
With Without 
finding finding P 
-------
Episodes of hypotension (systolic blood pressure <80 mm Hg) 717 1/5 <.01 
Metabolic acidosis (pH <7.3) 6/6 2/6 <.02 
Gastrointestinal bleeding (requiring blood transfusions) 6/6 2/6 <.02 
Coagulopathy (disseminated intravascular coagulation) 
Bacteremia 
-----
closporine and steroids. Five of the 11 who developed HSV 
hepatitis within 2 months of transplantation received OKT3, 
and 4 died. Three of six patients without OKT3 treatment died 
(P> .05). 
Discussion 
HSV hepatitis is one of the few emergencies in infectious 
diseases. If not diagnosed in time, it may lead quickly to DIe 
and death. Sporadic case reports have described fulminant 
hepatitis in both immunocompromised [8-13] and normal 
hosts [14-19]. We present here 12 cases of herpes hepatitis 
from one institution that occurred in liver, heart, or kidney 
transplant recipients. Typically, the course of the disease was 
rapid and the diagnosis was difficult. Seven of eight patients 
who died were not diagnosed until autopsy or within 24-48 h 
before their deaths. The four patients who survived were di-
agnosed relatively early and responded to treatment with acy-
clovir. No patient in this series had received acyclovir 
prophylaxis. 
There were two distinct groups of patients in this series as 
defined by diffuse or focal involvement of the liver. The only 
way to distinguish diffuse from focal HSV hepatitis is by bi-
opsy. Diffuse hepatitis was always fatal and was associated 
with diffuse necrosis of the liver, coagulopathy, and DIe (pa-
tients 2-4). Most patients with focal hepatitis also died, par-
5/5 317 <.05 
6/6 2/6 <.02 
ticularly if they had DIe or dissemination, which was 
diagnosed at autopsy. The difference in pathogenesis between 
focal and diffuse hepatitis is unknown. It is unclear whether 
diffuse hepatitis always starts with focal infiltration that, if 
recognized in time, can be cured with antiviral therapy or 
whether there was some basic pathogenetic difference between 
the two groups of patients. However, the primary cause of 
death, at least in the first group of patients, clearly was mas-
sive involvement of the liver leading to severe coagulopathy 
and liver failure. 
Lethal HSV hepatitis, coagulopathy, and DIe have been 
reported in both neonates and adults [20, 21]. In our series, 
five patients (42 %) developed DIe, and all died. Other clini-
cal situations associated with mortality were episodes of 
hypotension, metabolic acidosis, bacteremia, gastrointesti-
nal bleeding, and renal failure. Several reported cases ofHSV 
hepatitis with hypotension and hemodynamic instability were 
found at autopsy to have adrenal necrosis [22, 23]. In our 
series, two patients had diffuse hepatitis and coagulative necro-
sis with inclusion bodies in the adrenals (patients 1 and 8). 
Although herpetic skin lesions help in diagnosis, they were 
the exception rather than the rule, and the clinician should 
not rely on their presence [14, 24]. Only one patient had her-
petic skin lesions over the trunk and limbs (patient 1); he also 
had disseminated disease and died. 
When a clinician notes a transplant recipient who has fever, 
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progressive transaminase elevation, abdominal symptoms, and 
coagulopathy in the first month after transplantation, herpes 
hepatitis should be considered [14]. The empiric use of intra-
venous acyclovir in such patients, pending the results of a liver 
biopsy and viral cultures, seems warranted and may be lifesav-
ing [25]. 
Bacteremia, which is cornmon after liver transplantation 
[26], occurred in 50 % of the patients and was correlated with 
mortality. Other laboratory abnormalities associated with a 
fatal outcome were platelet counts below the median of 
45,OOO/mm3 and values above the medians for creatinine (3.5 
mg/dl), PTT (38 s), and percentage ofband forms (25%) at 
diagnosis. Elevated liver enzymes at diagnosis did not corre-
late with mortality. 
A comparison of CMV hepatitis with HSV hepatitis is im-
portant because both occur almost exclusively in the early 
posttransplant period. The clinical pictures of these diseases 
are distinct; CMV hepatitis is usually "smoldering" and rarely 
fulminant [27]. Also, with CMV hepatitis, one usually finds 
a low white blood cell count with atypical lymphocytosis and 
no leukocytosis or shift to the left. While CMV hepatitis is 
usually seen toward the end of the first and beginning of the 
second month after transplantation, HSV hepatitis usually oc-
curs earlier. The earliest case in this series occurred only 5 
days after transplantation. 
The mortality from primary HSV infection in seronegative 
patients was 75% (3/4) and in seropositive patients was 63% 
(5/8). The difference was not statistically significant. The de-
velopment of fulminant disease was more frequent in seronega-
tive patients (3/4) than in seropositive patients (2/8). However, 
this study shows that HSV hepatitis can occur as a reactiva-
tion infection. This is important because most HSV infec-
tions after transplantation represent reactivation oflatent virus 
[6]. We found that 78 % of patients in a large series of liver 
transplant recipients were seropositive for HSV before trans-
plantation [28]. 
The role of transmission has been addressed previously at 
this institution. One case was a 47-year-old man who devel-
oped fulminant HSV-l hepatitis with disseminated intravas-
cular coagulation 12 days after cadaveric renal transplantation 
(patient 3, table 1). We were unable to implicate the trans-
planted kidney as the source of HSV infection because both 
the donor and the recipient before transplantation were 
seronegative for HSV [2]. More recently, we have documented 
transmission of HSV from donor organ to recipient [3, 29]. 
In one instance [29], two renal transplant recipients had a com-
mon donor and both developed primary disseminated skin in-
fection with HSV-2. In the second instance [3], two recipients 
of cadaveric renal transplant developed a fatal fulminant HSV-2 
hepatitis. In both instances, the viral isolates from recipients 
were identical by restriction endonuclease polymorphism pat-
tern. Thus the infections were assumed to arise from a com-
mon source, the donor kidney. The donors were seropositive 
for both HSV-l and HSV-2. 
Prophylaxis against HSV infection after kidney and mar-
row transplantations has been shown to be effective [30, 31]. 
We instituted acyclovir prophylaxis in our kidney and liver 
transplant recipients in February 1989. No additional cases 
of HSV hepatitis have been seen since the last case of this 
series in July 1988. Thus, between October 1988 and April 
1990 1144 additional transplant operations were done in Pitts-
burgh, and there were no cases of HSV hepatitis. These data 
offer support for the use of acyclovir prophylaxis in the early 
posttransplant period. 
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